Investment In R&D For New TB Vaccines Critical To Ending Epidemic

The Hill: Tuberculosis epidemic desperately needs new vaccination strategies
José Luis Castro, executive director of the International Union Against Tuberculosis and Lung Disease

“…To defeat the TB epidemic, we need nothing short of a research-and-development revolution. … Currently, investment in TB research and development — especially in vaccines — is embarrassingly low. … We must keep driving research forward until we have a vaccine. Investing in R&D over the long term will mean future generations — our children and grandchildren — will not have to suffer from this devastating disease. … Public health victories that eliminate infectious diseases — or bring us to the brink of elimination — have never happened without a vaccine. The entire world — not just the hotspots — desperately needs new TB vaccines and vaccination strategies to bring an end to the TB epidemic” (11/30).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.